GEN Exclusives

More »

GEN News Highlights

More »
Oct 28, 2009

Oncodesign to Provide Sanofi-Aventis with Exclusive Cancer Models

  • Oncodesign signed a two-year service contract with sanofi-aventis, under which it will develop and provide the latter with exclusive experimental tumor-derived models for different types of cancer. Philippe Genne, Oncodesign CEO, suggests the the contract represents “a first for a service company, since it is a long-term collaboration that calls for us to supply experimental models to sanofi-aventis.”

    Oncodesign says that unlike traditional cancer models derived from cultured cell lines, its technology is based on patient-derived tumor tissue. Oncodesign has previously worked with sanofi-aventis on the CReMEC (creating a resource center for experimental cancer models) program. It was initiated in 2005 as part of the Medicin Paris Region competition pole to develop and characterize experimental models of colon cancer.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »